CaƱete, Baby Girl .
HRN: 29-23-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2026
AMPICILLIN 250MG (VIAL)
06/27/2026
07/04/2026
IV
45mg
Q 12
Prematurity
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines